Labshake search
Citations for Stemcell Technologies :
201 - 250 of 1025 citations for 7 Oxabicyclo 2.2.1 heptan 2 ol 4 methyl 1 1 methylethyl 1R 2S 4R rel 9CI since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2022Quote: ... and cultured in a 1:1 ratio of DMEM-F12 and NeuroCult NS-A Basal Medium (Human) (Stem Cell Technologies) with 1X N-2 supplement (Gibco) ...
-
bioRxiv - Molecular Biology 2024Quote: ... and differentiation protocol as reported.10 At day -1 iPSC were prepared in mTeSR™1 (StemCell Technologies Cambridge, MA) and plated at approximately 40 colonies per well on Matrigel pre-coated wells ...
-
bioRxiv - Developmental Biology 2020Quote: ... 1 mM dibutyryl cyclic-AMP (Stemcell Technologies, 73882), and 200 nM ascorbic acid (Stemcell Technologies,72132 ...
-
bioRxiv - Neuroscience 2021Quote: ... in mTeSR™1 medium (StemCell Technologies, 85850) and passaged in the presence of ROCK Inhibitor InSolution™ Y-27632 (Merck Millipore ...
-
bioRxiv - Cell Biology 2022Quote: ... coated plates in mTeSR™1 (StemCell Technologies) supplemented with 0.5% Penicillin-Streptomycin (ThermoFisher Scientific) ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 1 μM SB-431542 (StemCell Tech; #72232) to support formation of well-defined ...
-
bioRxiv - Cell Biology 2021Quote: ... bovine serum albumin (BSA; 1 %; Stem Cell Technologies), mSCF (10 ng/mL) ...
-
bioRxiv - Microbiology 2021Quote: ... coated wells in mTeSR-1 media (StemCell Technologies) supplemented with 100 μg/mL Primocin ...
-
bioRxiv - Bioengineering 2020Quote: ... iPSCs were maintained in mTeSR-1 (StemCell Technologies) on 6-well tissue culture plates coated with Matrigel® (Corning) ...
-
bioRxiv - Neuroscience 2021Quote: ... 1% (v/v) N2 Supplement-A (StemCell Technologies), 20 ng/ml Recombinant Human Brain-Derived Neurotrophic Factor (StemCell Technologies) ...
-
bioRxiv - Neuroscience 2021Quote: ... 1 U/mL Dispase II (STEMCELL Technologies, 07913), 2.5 U/mL Papain (Worthington Biochemical ...
-
bioRxiv - Cancer Biology 2022Quote: ... 1 mg/ml Heparin (Stem Cell Technologies, 7980), and NSC Proliferation Supplements (Stem Cell Technologies ...
-
bioRxiv - Neuroscience 2022Quote: ... 1 μM LDN 193189 (both Stem Cell Technologies), 1.5 μM IWR1 (Tocris) ...
-
bioRxiv - Genetics 2022Quote: ... with mTESR or mTESR-1 medium (StemCell Technologies) and incubated at 37 °C in a humidified atmosphere with 5% CO2 ...
-
bioRxiv - Cell Biology 2021Quote: ... and cultured in mTeSR™1 (STEMCELL Technologies). After successfully stabilizing of at least 2 clones per reprogrammed cell line ...
-
bioRxiv - Bioengineering 2021Quote: ... and 1 mg/ml DNase I (Stemcell Technologies) in DMEM (Gibco ...
-
bioRxiv - Neuroscience 2022Quote: ... 1 µM LDN 193189 (both Stem Cell Technologies), 1.5 µM IWR1 (Tocris) ...
-
bioRxiv - Neuroscience 2022Quote: ... 1 × NeuroCult SM1 without vitamin A (StemCell Technologies), and 1 × Antibiotic-Antimycotic ...
-
bioRxiv - Biophysics 2020Quote: ... supplemented with 1% Heparin Solution (STEMCELL Technologies, 07980), 2% Amphotericin B (Fungizone ...
-
bioRxiv - Cell Biology 2020Quote: ... in complete mTeSR™1 (Stem Cell Technologies) supplemented with 100 units/mL of penicillin-streptomycin (Gibco™ ...
-
bioRxiv - Systems Biology 2021Quote: ... and 1 µM PD0325901 (72184, Stem Cell Technologies) in 5% CO2 at 37°C.
-
Naked Mole-Rat Hematopoietic Stem and Progenitors are Highly Quiescent with an Inherent Myeloid BiasbioRxiv - Cell Biology 2021Quote: ... 0.75µM Stemregenin (SR-1; Stemcell Technologies Cat# 72342), modified as described (64) ...
-
bioRxiv - Genomics 2021Quote: ... serum-free mTeSR™1 medium (STEMCELL Technologies). Cells were passaged ∼1:10 at 80% confluency using ReLeSR (STEMCELL Technologies ...
-
bioRxiv - Cancer Biology 2021Quote: ... Mouse anti-Beta Tubulin (STEMCELL Technologies; 1:500); Rabbit anti-Olig2 (PhosphoSolutions ...
-
bioRxiv - Immunology 2019Quote: ... anti-CD38–FITC (clone AT-1, StemCell Technologies), anti-CD45–V500 (clone D058-1283 ...
-
bioRxiv - Developmental Biology 2022Quote: ... serum-free mTeSR™1 medium (STEMCELL Technologies). Cells were passaged ∼1:10 at 80% confluency using ReLeSR (STEMCELL Technologies ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 5 mg ml-1 dispase (STEMCELL Technologies) and 1 mg ml-1 DNAse (Sigma ...
-
bioRxiv - Neuroscience 2022Quote: ... 1 µM LDN193189 (STEMCELL Technologies, Vancouver, Canada, 72147), 3 µM CHIR99021 (STEMCELL Technologies ...
-
bioRxiv - Neuroscience 2022Quote: ... 1 U/mL Dispase II (STEMCELL Technologies, 07913), 2.5 U/mL Papain (Worthington Biochemical ...
-
bioRxiv - Immunology 2023Quote: ... 1 µg/ml low density lipoprotein (Stemcell Technologies), 60 µM ascorbic acid (Sigma) ...
-
bioRxiv - Bioengineering 2023Quote: ... anti CD34-AlexaFluor488 (#60013AD, Stemcell technologies, 1:100).
-
bioRxiv - Immunology 2023Quote: ... IGF-1 (40 ng/mL; Stem Cell Technologies), cholesterol-rich lipids (40 µg/mL ...
-
bioRxiv - Cancer Biology 2024Quote: ... and 1 μM LDN-193189 (StemCell Technologies, 72147). On day 7 ...
-
bioRxiv - Bioengineering 2023Quote: ... 1 mL gentle cell dissociation reagent (STEMCELL Technologies) was added to each well ...
-
bioRxiv - Neuroscience 2024Quote: ... 1 mM Dibutyryl-cAMP (#73882; Stem Cell Technology) and 200 nM Ascorbic Acid (#72132 ...
-
bioRxiv - Cancer Biology 2024Quote: ... 1% hydrocortisone stock solution (StemCell Technologies Cat#07925), and 0.04% heparin (StemCell Technologies Cat #07980) ...
-
bioRxiv - Immunology 2021Quote: ... cells were preactivated for 5 days with IL-2 and either 1:1 aAPCs or 25 μl/ml CD3/CD28/CD2 tetramer (ImmunoCult Human CD3/CD28/CD2 T Cell Activator, STEMCELL Technologies). L cells (ATCC CRL-2648 ...
-
bioRxiv - Neuroscience 2021Quote: ... organoids were cultured in media comprised of 1:1 mixture of the aforementioned differentiation media and BrainPhys neuronal medium (STEMCELL Technologies). These organoids were used for functional patch-clamp recordings.
-
bioRxiv - Neuroscience 2021Quote: ... The media was changed daily and the iPSC cultures were split into 1:6-1:10 every 5 days using ReLeSR (Stemcell Technologies).
-
bioRxiv - Cell Biology 2022Quote: The coating solution in the top channel was removed and replaced with so-called B/D complete medium: a 1:1 mixture of BEpiCM-b and DMEM medium (STEMCELL Technologies), supplemented with Bronchial Epithelial Cell Growth Supplement (ScienCell) ...
-
bioRxiv - Neuroscience 2020Quote: ... donor blood was diluted 1: 1 with phosphate buffered saline (PBS) and transferred into sterile SepMate 50 (STEMCELL Technologies, BC, Canada) as per manufacturer’s instructions ...
-
bioRxiv - Developmental Biology 2022Quote: ... Cells were cultured in feeder-free medium and grown on Matrigel-coated plates in cell medium containing 1:1 mTesR1: Essential 8 (StemCell Technologies, 85850 and Thermofisher A1517001 ...
-
bioRxiv - Bioengineering 2023Quote: ... 2.5 g of Hydrosil silicone components (1:1 wt) (101301; SILADENT) was added into each well of 6-well microwell culture plate (AggreWellTM400; STEMCELL Technologies) followed by centrifugation at 55 x g for 1 min and curing at 60 °C for 1 h ...
-
bioRxiv - Cancer Biology 2024Quote: ... pups were irradiated with sublethal dose (1 Gy) and thereafter engrafted with 1×105 human CD34+ cord blood cells (HLA-A24:02, Stemcell Technologies) through intrahepatic injection ...
-
bioRxiv - Bioengineering 2023Quote: ... CD34+ HSPCs at a concentration of 1 × 104 cells/mL were plated in 35 mm cell culture dishes in 1 mL Methocult H4230 medium (Stemcell Technologies) supplemented with 2% FBS ...
-
bioRxiv - Cancer Biology 2023Quote: ... Minced tissues were transferred with help of a sterile wide bore 200 µl pipette tip into a 1.8 ml cryo vial containing 1.2 ml A-mTE-D1 (300 IU ml-1 collagenase IV mixed with 100 IU ml-1 hyaluronidase; Stem Cell Technologies, 07912 ...
-
bioRxiv - Neuroscience 2024Quote: ... supplemented with RA (0.1 or 1 µM) and purmorphamine (0.5 or 0.125 µM) in combination with 1 μM CHIR99021 (STEMCELL Technologies; Cat. No. 72054), 2 μM DMH1 (Sigma-Aldrich ...
-
bioRxiv - Cell Biology 2024Quote: ... were seeded at 0.5-1 x 107 cells/ml in “phase 1 expansion medium” consisting of Stemspan SFEM (Stem Cell Technologies) supplemented with Stem Cell Factor (SCF ...
-
bioRxiv - Neuroscience 2021Quote: ... Cultures were fed every other day and passaged every 5–7 days by ReLeSR™ (STEMCELL Technologies).
-
bioRxiv - Bioengineering 2023Quote: ... The iPSCs were routinely passaged every 5-7 days using ReLeSR™ Passaging Reagent (Stemcell Technologies, Canada). The iPSCs were then differentiated into SCPCs based on a modified protocol to generate spinal motor neurons (Hor et al. ...